A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 38/02 (2006.01) A61K 38/17 (2006.01) A61P 11/16 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2064604
Disclosed is a prophylactic preparation for inhibit-ing pulmonary oxygen toxicity in a patient requiring elevated levels of oxygen inhalation, which comprises: an effective amount of an agent selected from the group consisting of: a) an antibody capable of binding to ICAM-1; b) a fragment of the antibody (a), the fragment being capable of binding to ICAM-1; c) ICAM-1, being substantially free of natural contami- nants; d) a functional derivative of ICAM-1; e) an antibody capable of binding to a member of the CD18 family of glycoproteins; f) a fragment of the antibody (e), the fragment being capable of binding to a member of the CD18 family of glycoproteins; g) a member of the CD18 family of glycoproteins, being substantially free of natural contaminants; and h) a functional derivative of a member of the CD18 family of glycoproteins in admixture with a pharmaceutically acceptable carrier.
Letts L. Gordon
Wegner Craig D.
Boehringer Ingelheim Pharmaceuticals Inc.
Fetherstonhaugh & Co.
LandOfFree
Method for inhibiting pulmonary oxygen toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting pulmonary oxygen toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting pulmonary oxygen toxicity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1745686